Archive | 4D Meets AI RSS feed for this section

Announcing Healthtech Partnering Week, March 15-19, 2021

21 Jan

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

Life Science Nation (LSN) is pleased to announce the next Healthtech Partnering Week takes place March 15-19, 2021. Super early bird registrations save $100 when they sign up by January 29!

Healthtech Partnering Week is an early-stage fundraising vessel, featuring three back-to-back digital partnering conferences: Redefining Early Stage Investments (RESI), 4D Meets AI, and Longevity, Health & Innovation (LHI), which is co-organized with Mary Furlong & Associates. The previous Healthtech Partnering Week, held in conjuncture with J.P. Morgan’s virtual Health Care Conference, hosted 20 panels, 10 live pitch sessions, 2,000+ meetings, and welcomed 600+ investors actively seeking opportunities in healthcare and life science.

Each conference is designed for early-stage fundraising executives to reach potential partners based on product fit and stage of development. Many have begun relationships that have led to millions invested. LSN is proud to be a regular part of the early-stage fundraising ecosystem within life science and healthcare and invites you to join us in March!

Learn More at

Innovator’s Pitch Challenge Applications Open at LSN Healthtech Partnering Week

21 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN)’s Healthtech Partnering Week serves as a vehicle for early-stage fundraising within life science and healthcare with many valuable features, including a match-based partnering system and hours of educational materials like entrepreneur bootcamps, branding workshops, and investor panels. However, one of the most powerful additions to the digital partnering space is the Innovator’s Pitch Challenge (IPC).

The IPC highlights exceptional early-stage companies and provides them the opportunity to pitch live to a panel of investor judges. Accepted companies submit pitching materials, including a pitch deck, executive summary, and a long-form pitch video that are sent to judges to review prior to live Q&A sessions. During the live session, each company will present a brief elevator pitch and participate in a Q&A from the judges and audience.

IPC applications are open until Friday, February 19th. Accepted applicants who sign up before Friday, January 29 will also save $100 on registration. Learn more about the IPC and how it can help boost your exposure and increase visibility to hundreds of investors and strategic partners!

The Lost Art of Following Up

14 Jan

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

Following up with a previous correspondence is an inevitability in the digital age, so when did entrepreneurs start taking a lack of response as the recipient’s lack of interest in their message? While this may be true in some instances, it is not always the case. A timely, thoughtful follow-up strategy is one of the best communication tools any fundraising executive may possess, and it often makes the difference between a meeting and another introduction gone unanswered. Such a powerful skillset deserves its own process, so we’ve broken it down:

  1. Introduction: The first message is the one where you introduce yourself and your company, as well as request a meeting. It’s ok if your target investor does not respond immediately (hence this system). To help them understand your position, it’s important to include the following:
      1. Company tagline (5-6 words explaining who you are and what you do)
      2. Elevator pitch (1-3 sentences describing the company and tech)
      3. Technology differentiation, product innovation, or market position
      4. Raise and milestone information
  2. Follow Up 1 (Product/Tech): Why is your product and technology unique? Is it first-in-class? Best-in-class? This is your opportunity to dive into your company’s differentiated value.
  3. Follow Up 2 (Management/Team): Highlight your management and team. How have your people had a notable impact on the business development. What makes your people special?
  4. Follow Up 3 (One Pager): Condense all the important messages you’ve already shared into a one-page tear sheet for quick and easy reference later. Even if the investor you’ve targeted is not a fit, this will make it easier for them to share your company with another.

(Tear Sheet Sample)

Life Science Nation (LSN) has helped hundreds of early-stage startups within life science and healthcare get their branding and messaging straight in order to connect with investors who are a fit for their product and stage of development. We’ve seen great companies neglect the finer details, like a comprehensive follow-up strategy, and hope this helps you along your journey to funding and beyond!

Introducing the Innovator’s Pitch Challenge Finalists!

7 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN)’s Inaugural Healthtech Partnering Week launches next week, which means the Innovator’s Pitch Challenge (IPC) is on! The IPC is an opportunity for early-stage, fundraising CEOs to pitch directly to a panel of judges, who follow up with a live Q&A session.

How does it work? The finalist companies deliver pitching materials, including a comprehensive slide deck, executive summary, and a long form pitch video to be hosted on a dedicated webpage the judges review prior to their live session. Sessions are split up by sectors and are designed to match up companies with investors actively seeking opportunities in their space. During the live session, companies deliver a brief short form pitch, which is then followed by a Q&A period with the judges.

Each event sees an incredible line up of early-stage companies delivering promising tech to advance life science and healthcare. LSN is proud to host this powerful meeting of the minds.

Innovator’s Pitch Challenge Finalists

J.P. Morgan Week Update: The Perfect Venue to Launch LSN Healthtech Partnering Week

7 Jan

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

It’s that time of year again! J.P. Morgan’s Annual Healthcare Conference has spawned countless concurrent healthcare conferences taking advantage of the influx of industry professionals eager to network and make deals for nearly forty years. The Redefining Early-Stage Investments (RESI) conference series has been a popular addition for several years, and it seemed the obvious choice when we looked to launch our own Healthtech Partnering Week.

Over the past ten months, as many industries slowed down, Life Science Nation (LSN)’s partnering events have ramped up, delivering an increased number of one-on-one meetings between fundraising early-stage companies and investors. The metrics speak for themselves, as we’ve seen an average of 1400+ meetings take place over three days of digital partnering, proving that digital partnering works with investors pulling the deal-making trigger. The proof-of-concept, preclinical and clinical trial money is flowing.

Learn more about Healthtech Partnering Week and join the 500+ investors.

What’s the difference?

MATCHING LSN’s customized partnering system enables fundraising CEOs, investors, and strategic partners to seek opportunities based on several search criteria, most importantly including product fit and stage of development, helping attendees avoid wasted meetings, which can amount to more than half the meetings booked at standard partnering conferences. LSN’s database of thousands of investors and start-ups provides detailed profiles that help attendees increase their chances of success by matching with the best partners for them.

MESSAGING LSN has interviewed thousands of investors in order to learn what their criteria are for taking a meeting and engaging with an investment prospect. The trends we found have been written into a book (FREE PDF COPY) designed to help the scientist-entrepreneur understand how to get their branding and messaging straight. This starts with a cogent 5–7-word tagline, a lucid 6-7-sentence elevator pitch, and a one-page data sheet that succinctly presents all relevant information a potential investor would need at first glance. Finally, tell your unique story through a two-page executive summary and elaborate on your technology in a 10–12-page pitch deck.

FOLLOW-UP Partnering is an extremely competitive contact sport. You need to get your company and message above the noise. Investors and strategic partners are inundated with meeting requests, and if you do not have a compelling tactical plan to go after and secure meetings, you run the risk of getting only 4-6 meetings, instead of 15-20+. It’s a numbers game – we don’t make the rules, but we know how to play by them.

LSN has developed a 4-step follow-up process. The concept of follow-up stops most early-stage entrepreneurs in their tracks and thus limits their interaction with targeted partners. We walk a fundraising CEO through all these issues and set them on the right path through our content, bootcamps and seminars. Preparing CEOs for partnering success is rarely given enough attention, and LSN is passionate about using its insight to help deal-flow to promising teams and their tech.

Check out more tips on partnering and a tutorial of the LSN system. There’s still time to register for events at Healthtech Partnering Week. Don’t miss out!

Introducing the 4D Meets AI Panelists

3 Dec

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

4D Meets AI is partnering conference designed for innovators and investors on the cutting-edge of AI technology applications in life science and healthcare. In addition to Life Science Nation (LSN)’s premier partnering platform, 4D Meets AI delivers insight via pre-recorded panel discussions on the early-stage ecosystem from both investors and founders. The panel agenda features active and engaging investors and industry leaders developing creative healthcare solutions through the power of AI technology.

Sign up for 4D Meets AI at LSN’s Healthtech Partnering Week, January 11-15, 2021, and get to know key industry players advancing the future of the 4Ds – Drugs, Devices, Diagnostics, and Digital Health.

Drugs: Applications
Exploring Drug Discovery and Development through the Lens of AI Technology Enabling Innovation

Moderator: Christopher Locher, PhD, Founder & CEO, Versatope Therapeutics

  • Sean Ekins, PhD, Founder & CEO, Collaborations Pharmaceuticals
  • David Harel, MBA, Co-Founder & President, CytoReason
  • Laura Towart, Founder & CEO, MyPersonalTherapeutics
  • Jonathan Ward, MBA, Co-Founder & CEO, Genome Biologics

Drugs: Investors
Investors Working in & Seeking Therapeutic Opportunities

Moderator: Ronjon Nag, PhD, Founder & Managing Director, R42 Group

  • Kan Chen, PhD, Principal, Qiming Venture Partners
  • Weiyong Sun, MD, PhD, MBA, Senior Director, Searching and Evaluation, Global Business Development, Daiichi Sankyo Group

Additional Panelists to be Announced

Devices: Applications
Sensors, Wearables & More Enabling Patient Monitoring & Disease Management

Moderator: John Cromwell, MD, CMO, Entac Medical

  • Maria Arvanitidou, Head, Corporate Development & Partnerships, Sentio Solutions
  • Hadeel Ayoub, PhD, Founder & CTO, BrightSign Technology
  • Loewen Cavill, CEO, AuraBlue
  • Anthony Ortiz, Founder & CEO, Fitly

Devices: Investors
Medical Device Investors on the State of the Market

Moderator: Geoff Pardo, MBA, Partner, Gilde Healthcare

  • Amy Belt Raimundo, MBA, Managing Director, Kaiser Permanente Ventures
  • James Eadie, MD, Partner, Santé Ventures
  • Bryan Grulke, MBA, Partner, Volcano Capital

Additional Panelists to be Announced

Diagnostics: Applications
Fast, Accurate & Accessible Disease Detection

Moderator: Michael Abramoff, MD, PhD, Founder & Executive Chairman, Digital Diagnostics

  • Chris Fernandez, Co-Founder & CEO, EnsoData
  • Hui Li, PhD, Co-Founder & CEO, Singularity AI
  • Geetha Manjunath, PhD, Founder & CEO, Niramai Health Analytix

Additional Panelists to be Announced

Diagnostics: Investors
Investors Seeking Diagnostic Innovation
Moderator to be Announced


  • Lavanya Bhamidipati, MBA, Investment Associate, InHealth Ventures
  • Jun Deng, PhD, Investment Partner, Joyance Partners
  • Steve Seuntjens, MiM, Partner, Personal Health Solutions
  • Prachi Sinha, MBA, Healthcare Investment Head, Axilor Ventures

Additional Panelists to be Announced

Digital Health: Applications
Technologies Aiding Clinical Optimization & Patient Treatment
Moderator: Michelle Perugini, PhD, CEO, Presagen

  • Zack Dvey-Aharon, PhD, Co-Founder & CEO, AEYE Health
  • Umar Naeem Ahmad, Co-Founder & CEO, Abtrace
  • Mylene Yao, MD, Co-Founder & CEO, Univfy
  • Maya Zlatanova, MIB, Co-Founder & CEO, FindMeCure

Digital Health: Investors
How Digital Health Companies Can Stand Out

Moderator: Yizhen Dong, MBA, Partner, Global Founders Capital

  • Hamzeh Abdul-Hadi, Principal, Hikma Ventures
  • Gary Gershony, MD, General Partner, Baymed Venture Partners
  • Joseph Mocanu, PhD, Managing Partner, Verge HealthTech Fund
  • Julianne Roseman, Venture Associate, Plug and Play Ventures

A Conversation with Helena Cowley, CEO of Oxidien Pharmaceuticals

3 Dec

By Rory McCann, Marketing Manager & Conference Producer, LSN

Helena Cowley, MS, MBA is CEO of Oxidien Pharmaceuticals, a therapeutics company mitigating kidney stone disease by using enzyme compounds to treat secondary hyperoxaluria. We recorded our chat about the early days of Oxidien and how they’ve navigated the fundraising landscape. We discuss conferences, networking, and tools to give early-stage companies an edge when meeting with strategic partners.

To learn more about RESI and Life Science Nation’s premier partnering events this January, visit Digital RESI January super early bird rates apply until December 4, so sign up today to start meeting with investors and strategic partners to jumpstart your 2021 fundraising goals!

%d bloggers like this: